Crinetics Pharmaceuticals (CRNX) Profit After Tax: 2017-2025
Historic Profit After Tax for Crinetics Pharmaceuticals (CRNX) over the last 9 years, with Sep 2025 value amounting to -$130.1 million.
- Crinetics Pharmaceuticals' Profit After Tax fell 69.33% to -$130.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$423.1 million, marking a year-over-year decrease of 52.24%. This contributed to the annual value of -$298.4 million for FY2024, which is 39.10% down from last year.
- Per Crinetics Pharmaceuticals' latest filing, its Profit After Tax stood at -$130.1 million for Q3 2025, which was down 12.50% from -$115.6 million recorded in Q2 2025.
- In the past 5 years, Crinetics Pharmaceuticals' Profit After Tax registered a high of -$22.9 million during Q1 2021, and its lowest value of -$130.1 million during Q3 2025.
- Its 3-year average for Profit After Tax is -$77.8 million, with a median of -$74.1 million in 2024.
- Data for Crinetics Pharmaceuticals' Profit After Tax shows a maximum YoY slumped of 72.41% (in 2022) over the last 5 years.
- Over the past 5 years, Crinetics Pharmaceuticals' Profit After Tax (Quarterly) stood at -$26.1 million in 2021, then plummeted by 72.41% to -$45.0 million in 2022, then crashed by 33.58% to -$60.1 million in 2023, then tumbled by 34.11% to -$80.6 million in 2024, then slumped by 69.33% to -$130.1 million in 2025.
- Its Profit After Tax stands at -$130.1 million for Q3 2025, versus -$115.6 million for Q2 2025 and -$96.8 million for Q1 2025.